A carregar...

Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer

CONTEXT: Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The long-term prognosis is generally excellent. Due to a paucity of data, debate exists regarding the benefit of adjuvant radioactive iodine therapy (RAI) for intermediate-risk patients. OBJECTIVE: The objective of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Ruel, Ewa, Thomas, Samantha, Dinan, Michaela, Perkins, Jennifer M., Roman, Sanziana A., Sosa, Julie Ann
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399282/
https://ncbi.nlm.nih.gov/pubmed/25642591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!